As shown in Fig. 2D, if we categorized all the 99 cases of esophageal cancer patients into EMT subgroup (n = 60) and non-EMT subgroup (n = 39) based on the evaluation of E-cadherin as well as Vimentin expression levels. This evidence concerns the gene VIM and esophageal cancer.